Aldámiz Echevarría, TeresaTejerina, FranciscoFanciulli, ChiaraDíez, CristinaPérez, LeireBellón Cano, José MaríaEspinosa, NuriaMoreno Guillén, SantiagoArcos Rueda, María del MarSuárez García, Inés Et. al.2026-08-272026-08-272026Aldámiz‐Echevarria, T., Tejerina, F., Fanciulli, C., Diez, C., Perez, L., Bellón, J. M., Espinosa, N., Guillén, S. M., Del Mar Arcos‐Rueda, M., Montero‐Alonso, M., García‐Fraile, L., Asensi, V., López, M. F., Corona‐Mata, D., Cabello‐Úbeda, A., Manso, M. G., Iribarren, J. A., Pérez‐Martínez, L., Valls, M. R. A., … CoRIS Cohort. (2026). Hodgkin and non‐Hodgkin lymphomas in the post‐antiretroviral therapy era according to HIV virological suppression. HIV Medicine, 27(8), 1312-1332. https://doi.org/10.1111/hiv.702571464-26621468-1293https://hdl.handle.net/11268/17384Lymphomas remain among the most frequent HIV-associated malignancies, with risk persisting despite effective virological control. This study describes the clinical, epidemiological and prognostic characteristics of lymphomas (both Hodgkin and non-Hodgkin) in people living with HIV, according to virological suppression at diagnosis and assesses lymphoma-related mortality at 1 year and overall survival at 5 years.engAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/Departamento clínicoVIHLinfomaVirologíajournal article10.1111/hiv.70257open accessSidaVirologíaMedicina preventivaGoal 3: Ensure healthy lives and promote well-being for all at all ages